SP could go either way as these early stage biotechs are so volatile with traders taking fast profits but if SP holds above 40 cents then that would be a good base before next leg up. If the expected Ph1 intravenous trial result is announced soon then IMO previous 52 week high of 52 cents could be tested soon also.